Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2005 1
2014 2
2015 2
2017 1
2018 2
2019 2
2020 1
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin's Lymphoma.
Connors JM, Jurczak W, Straus DJ, Ansell SM, Kim WS, Gallamini A, Younes A, Alekseev S, Illés Á, Picardi M, Lech-Maranda E, Oki Y, Feldman T, Smolewski P, Savage KJ, Bartlett NL, Walewski J, Chen R, Ramchandren R, Zinzani PL, Cunningham D, Rosta A, Josephson NC, Song E, Sachs J, Liu R, Jolin HA, Huebner D, Radford J; ECHELON-1 Study Group. Connors JM, et al. N Engl J Med. 2018 Jan 25;378(4):331-344. doi: 10.1056/NEJMoa1708984. Epub 2017 Dec 10. N Engl J Med. 2018. PMID: 29224502 Free PMC article. Clinical Trial.
Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial.
Dimopoulos MA, Gay F, Schjesvold F, Beksac M, Hajek R, Weisel KC, Goldschmidt H, Maisnar V, Moreau P, Min CK, Pluta A, Chng WJ, Kaiser M, Zweegman S, Mateos MV, Spencer A, Iida S, Morgan G, Suryanarayan K, Teng Z, Skacel T, Palumbo A, Dash AB, Gupta N, Labotka R, Rajkumar SV; TOURMALINE-MM3 study group. Dimopoulos MA, et al. Lancet. 2019 Jan 19;393(10168):253-264. doi: 10.1016/S0140-6736(18)33003-4. Epub 2018 Dec 10. Lancet. 2019. PMID: 30545780 Clinical Trial.
Potential value of pre-planned imaging of bone disease in multiple myeloma.
Gundesen MT, Asmussen JT, Schjesvold F, Vangsted AJ, Helleberg C, Haukås E, Silkjær T, Teodorescu EM, Jensen BA, Slørdahl TS, Nahi H, Waage A, Abildgaard N, Lund T; Nordic Myeloma Study Group. Gundesen MT, et al. Among authors: jensen ba. Blood Cancer J. 2023 Jul 7;13(1):105. doi: 10.1038/s41408-023-00880-0. Blood Cancer J. 2023. PMID: 37419876 Free PMC article. No abstract available.
Strategies to improve patient-reported outcome completion rates in longitudinal studies.
Nielsen LK, King M, Möller S, Jarden M, Andersen CL, Frederiksen H, Gregersen H, Klostergaard A, Steffensen MS, Pedersen PT, Hinge M, Frederiksen M, Jensen BA, Helleberg C, Mylin AK, Abildgaard N. Nielsen LK, et al. Among authors: jensen ba. Qual Life Res. 2020 Feb;29(2):335-346. doi: 10.1007/s11136-019-02304-8. Epub 2019 Sep 23. Qual Life Res. 2020. PMID: 31549365 Free PMC article.
In multiple myeloma, monthly treatment with zoledronic acid beyond two years offers sustained protection against progressive bone disease.
Lund T, Gundesen MT, Juul Vangsted A, Helleberg C, Haukås E, Silkjær T, Asmussen JT, Manuela Teodorescu E, Amdi Jensen B, Schmidt Slørdahl T, Nahi H, Waage A, Abildgaard N, Schjesvold F; Nordic Myeloma Study Group. Lund T, et al. Among authors: amdi jensen b. Blood Cancer J. 2024 Apr 15;14(1):65. doi: 10.1038/s41408-024-01046-2. Blood Cancer J. 2024. PMID: 38622134 Free PMC article. No abstract available.
Causes of early death in multiple myeloma patients who are ineligible for high-dose therapy with hematopoietic stem cell support: A study based on the nationwide Danish Myeloma Database.
Holmström MO, Gimsing P, Abildgaard N, Andersen NF, Helleberg C, Clausen NA, Klausen TW, Frederiksen M, Kristensen DL, Larsen H, Pedersen PT, Andersen KT, Pedersen RS, Jensen BA, Gregersen H, Vangsted AJ. Holmström MO, et al. Among authors: jensen ba. Am J Hematol. 2015 Apr;90(4):E73-4. doi: 10.1002/ajh.23932. Epub 2015 Feb 2. Am J Hematol. 2015. PMID: 25561348 Free article. No abstract available.
Evaluation of clinical trial eligibility and prognostic indices in a population-based cohort of systemic peripheral T-cell lymphomas from the Danish Lymphoma Registry.
Pedersen MB, Hamilton-Dutoit SJ, Bendix K, Møller MB, Nørgaard P, Johansen P, Ralfkiaer E, Brown Pde N, Hansen PB, Jensen BA, Madsen J, Schöllkopf C, d'Amore F. Pedersen MB, et al. Among authors: jensen ba. Hematol Oncol. 2015 Dec;33(4):120-8. doi: 10.1002/hon.2153. Epub 2014 Jul 23. Hematol Oncol. 2015. PMID: 25052551
Role of routine imaging in detecting recurrent lymphoma: A review of 258 patients with relapsed aggressive non-Hodgkin and Hodgkin lymphoma.
El-Galaly TC, Mylam KJ, Bøgsted M, Brown P, Rossing M, Gang AO, Haglund A, Arboe B, Clausen MR, Jensen P, Pedersen M, Bukh A, Jensen BA, Poulsen CB, d'Amore F, Hutchings M. El-Galaly TC, et al. Among authors: jensen ba. Am J Hematol. 2014 Jun;89(6):575-80. doi: 10.1002/ajh.23688. Epub 2014 Feb 24. Am J Hematol. 2014. PMID: 24493389 Free article.
11 results